| 74960-6 |
valGANciclovir^trough |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
valGANciclovir [Mass/volume] in Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74960-6 |
|
|
|
|
Both |
|
|
|
0 |
valGANciclovir Trough Plas-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.48 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 74961-4 |
10-Hydroxycarbazepine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated 10-Hydroxycarbazepine [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74961-4 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated 10OH-Carbazepine Trough SerPl |
|
|
|
|
|
10,11-dihydro-10-hydroxycarbamazepine; 10-Hydroxy carbazepine; 10-hydroxycarbamazepine; 10-Monohydroxyoxcarbazepine; 10-OH-carbazepine; 10OH-Carbazepine; DRUG/TOXICOLOGY; Drugs; Level; Licarbazepine; Mass concentration; Oxcarbazepine metabolite; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 74962-2 |
Maprotiline^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Maprotiline [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74962-2 |
|
|
|
|
Both |
|
|
|
0 |
Maprotiline Trough SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Level; Ludiomil; Mass concentration; Novartis; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 74963-0 |
Promethazine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Promethazine [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74963-0 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Promethazine Trough SerPl-mCn |
|
|
|
|
|
Atosil; Avomine; DRUG/TOXICOLOGY; Drugs; Fargan; Farganesse; Lergigan; Level; Mass concentration; Phenergan; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Promethegan; Prothiazine; QNT; Quan; Quant; Quantitative; Random; Receptozine; Romergan; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sominex; SR |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 74964-8 |
Gabapentin^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Gabapentin [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74964-8 |
|
|
|
|
Both |
|
|
|
0 |
Gabapentin Trough SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Horizant; Level; Mass concentration; Neurontin; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 74965-5 |
Haloperidol^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Haloperidol [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74965-5 |
|
|
|
|
Both |
|
|
|
0 |
Haloperidol Trough SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Haldol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Serenace; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 74966-3 |
Acetaminophen^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Acetaminophen [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74966-3 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated APAP Trough SerPl-mCnc |
|
|
|
|
|
ACET; Acetamidophenol; Acetaminoph; Acetominophen; APAP; c209; C55; DRUG/TOXICOLOGY; Drugs; Hydroxyacetanilide; Level; Mass concentration; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tylenol; u209 |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 74967-1 |
Adrenal cortex Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
Adrenal cortex IgG Ab [Presence] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
74967-1 |
|
IF |
|
|
Both |
|
|
|
0 |
Adrenal cortex IgG Ser Ql IF |
|
|
|
|
|
ABS; Aby; ACA; ACIF; Adrnl; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF |
2.56 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 74968-9 |
Norsertraline^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Norsertraline [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74968-9 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Norsertraline Trough SerPl-mC |
|
|
|
|
|
Desmeth; Desmethylsertraline; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Sertraline metabolite; Serum; Serum or plasma; Setralinemetab; SR |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 74969-7 |
Methotrimeprazine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Methotrimeprazine [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74969-7 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Methotrimeprazine Trough SerP |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Hirnamin; Lepurin; Lerium; Levamin; Level; Levohalte; Levomazine; Levomeprazine; Levomeproma; Levomepromazin; Levomepromazina; Levomepromazine; Levomezine; Levonormal; Levopromazine; Levoprome; Levotomin; Levozan; Levozin; Mass concentration; Methotrimeprazine; Milezin; Minozinan; Neozine; Neuractil; Neurocil; Neurozil; Novo-Meprazine; Nozinan; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Procrazine; QNT; Quan; Quant; Quantitative; Random; Ronexine; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinogan; Sofmin; Specia 246; SR; Tisercin; Tisercine; Tisercinetta; Tisercinettes; Veractil |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 7497-1 |
Cheese mold type basophil bound Ab |
ACnc |
Bld |
Pt |
Qn |
LHR |
|
ACTIVE |
Cheese mold type triggered histamine release [Units/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
7497-1 |
|
LHR |
|
|
Both |
|
|
|
0 |
Cheese Mold BasoBnd Ab Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Associated; Autoantibodies; Autoantibody; Baso; BasoBnd Ab; Basophil release; Basophils; Basos; Blood; bnd; Bph; f082; f82; Leukocyte histamine reaction; Leukocyte histamine release; Mould; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC release; Whole blood |
2.69 |
1.0h(2) |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 74970-5 |
Acetylsalicylate^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Acetylsalicylate [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74970-5 |
|
|
|
|
Both |
|
|
|
0 |
Acetylsalicylate Trough SerPl-mCnc |
|
|
|
|
|
Acetylsalicylic acid; ASA; Aspirin; c207; c217; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 74971-3 |
Clopenthixol^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Clopenthixol [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74971-3 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Clopenthixol Trough SerPl-mCn |
|
|
|
|
|
Ciatyl; Cisordinol; Clopixol; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Sedanxol; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sordinol; SR; Zuclopenthixol |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 74972-1 |
9-Hydroxyrisperidone^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated 9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74972-1 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated 9OH-risperiDONE Trough SerPl- |
|
|
|
|
|
9-Hydroxy risperidone; 9-Hydroxy-risperidone; 9-OH-Risperidone; 9OH-risperidone; DRUG/TOXICOLOGY; Drugs; Invega; Level; Mass concentration; Paliperidone; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Risperidone metabolite; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 74973-9 |
carBAMazepine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
carBAMazepine [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74973-9 |
|
|
|
|
Both |
|
|
|
0 |
carBAMazepine Trough SerPl-mCnc |
|
|
|
|
|
Carbamazapine; Carbamezapine; Carbazepine; CRBM; DRUG/TOXICOLOGY; Drugs; Epitol; Level; Mass concentration; Neuro; Neurology; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tegretol; Teril |
2.48 |
2.48 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 74974-7 |
carBAMazepine.free^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
carBAMazepine free [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74974-7 |
|
|
|
|
Both |
|
|
|
0 |
carBAMazepine free Trough SerPl-mCnc |
|
|
|
|
|
Carbamazapine; carBAMazepine free; Carbamezapine; Carbazepine; CRBM; DRUG/TOXICOLOGY; Drugs; Epitol; FR; Level; Mass concentration; Neuro; Neurology; Non-protein bound; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tegretol; Teril |
2.48 |
2.48 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 74975-4 |
Nordiazepam^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Nordiazepam [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74975-4 |
|
|
|
|
Both |
|
|
|
0 |
Nordiazepam Trough SerPl-mCnc |
|
|
|
|
|
Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Pl; Plasma; Plsm; Point in time; Praxadium; Prazepam metabolite; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stilny; Tranxilium N; Vegesan |
2.48 |
2.48 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 74976-2 |
Phenytoin^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Phenytoin [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74976-2 |
|
|
|
|
Both |
|
|
|
0 |
Phenytoin Trough SerPl-mCnc |
|
|
|
|
|
DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; DRUG/TOXICOLOGY; Drugs; Epanutin; Fenantoin; Lehydan; Level; Mass concentration; Phenhydan; PHYT; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinergina; SR; Zentropil |
2.48 |
2.48 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 74977-0 |
Transferrin |
MRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Transferrin [Mass/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mg/24 H |
|
|
|
|
|
|
CHEM |
|
74977-0 |
|
|
|
|
Both |
|
|
|
0 |
Transferrin 24h Ur-mRate |
|
|
|
|
|
1 day; 24 hours; 24HR; Chemistry; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; Siderophilin; Tf; Trf; TRFRN; UA; UR; Urn |
2.48 |
2.48 |
|
|
|
|
|
|
|
mg/(24.h) |
|
|
|
0 |
| 74978-8 |
Cerebroside sulfatase & N-Acetylgalactosamine-4-Sulfatase panel |
CCnt |
WBC |
Pt |
- |
|
|
ACTIVE |
Cerebroside sulfatase and N-Acetylgalactosamine-4-Sulfatase panel [Enzymatic activity/mass] - Leukocytes |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
74978-8 |
|
|
|
|
Order |
|
|
|
0 |
Arylsulfatase A+ B Pnl WBC-cCnt |
|
|
|
|
|
Aryl sulfatase A; Aryl sulfatase B; Arylsulfatase A; Arylsulfatase A+ B Pnl; Arylsulfatase A+B; Arylsulfatase B; Catalytic Content; Chemistry; GalNAc6S sulfatase; Leukocytes; Maroteaux-Lamy disease; Metachromatic leucodystrophy; MPS VI; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; rh4S; rhASB; WBCs; White blood cells |
2.48 |
2.48 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 74979-6 |
Urate |
SCnc |
BAL |
Pt |
Qn |
|
|
ACTIVE |
Urate [Moles/volume] in Bronchoalveolar lavage |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
74979-6 |
|
|
|
|
Both |
|
|
|
0 |
Urate BAL-sCnc |
|
|
|
|
|
Bronchial alveolar lavage; Bronchoalveolar lavage; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; Urates; Uric acid |
2.48 |
2.48 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 7498-9 |
Chrysonilia sitophila Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Chrysonilia sitophila IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
7498-9 |
|
|
|
|
Both |
|
|
|
0 |
C sitophila IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C sitophila; Immune globulin E; Immunoglobulin E; Monilia sitophila; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 74980-4 |
LORazepam^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
LORazepam [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74980-4 |
|
|
|
|
Both |
|
|
|
0 |
LORazepam Trough SerPl-mCnc |
|
|
|
|
|
Ativan; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 74981-2 |
Pimozide^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Pimozide [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74981-2 |
|
|
|
|
Both |
|
|
|
0 |
Pimozide Trough SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 74982-0 |
FLUoxetine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
FLUoxetine [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74982-0 |
|
|
|
|
Both |
|
|
|
0 |
FLUoxetine Trough SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Prozac; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
